CD274 and pancreatic neoplasm: The cellular source of PD-L1 cannot be pinpointed, nonetheless, a previous study that evaluated PD-L1 protein expression by immunohistochemical staining of pancreatic cancer tissue samples, revealed that tumors classified as PD-L1-positive had significantly less infiltrating T-cells and patients experienced worse overall survival (67).